Drug-resistant Malaria

Date: February 22, 2015

Malaria Artemisinin chloroquine

Drug-resistant malaria found at Indo-Myanmar Border


The Lancet Infectious Diseases journal of the Oxford University have have detected drug-resistant malaria at the Indo- Myanmar border. It has found that this diesese is at the verge of entering India. Experts said the development was "alarming" and an "enormous threat".

These  drug-resistant malaria parasite have ability to nutralise the effects of Artemisinin which is normally given as part of combination therapy to fight malaria. It has been spreading since it emerged in South-east Asia. Primarily artemisinin-resistant malaria has been detected in South Asian countries like Cambodia, Laos, Thailand, Vietnam and Myanmar.

 K13 a known genetic signal of artemisinin drug resistance.


It is found that South-East Asia have the rise of resistance to both chloroquine and artemisinin. Mainly it is due to lower levels of natural malaria immunity exist in the region than in Africa.

Earlier, drug-resistant malaria parasite to Chloroquine was discovered in 1957 around the border between Cambodia and Thailand. Deaths from malaria have nearly halved since 2000, and the infection now kills about 584,000 people each year. But drug-resistant malaria parasite may threat to global health in future.